Latest & greatest articles for hepatitis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hepatitis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hepatitis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hepatitis

121. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update Full Text available with Trip Pro

Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer (...) review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update Ru HAN, Junwen ZHOU, Clément François, Mondher Toumi Ru HAN Aix-Marseille Universite Corresponding Author ORCiD: https://orcid.org

2019 Research Square

122. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update Full Text available with Trip Pro

Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer (...) review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update Ru HAN, Junwen ZHOU, Clément François, Mondher Toumi Ru HAN Aix-Marseille Universite Corresponding Author ORCiD: https://orcid.org

2019 Research Square

123. Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement. Full Text available with Trip Pro

Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement. Screening for hepatitis B virus (HBV) infection during pregnancy identifies women whose infants are at risk of perinatal transmission. Data from a nationally representative sample showed a prevalence of maternal HBV infection of 85.8 cases per 100 000 deliveries from 1998 to 2011 (0.09% of live-born singleton deliveries in the United States). Although (...) commissioned a reaffirmation evidence update to identify substantial new evidence sufficient enough to change the prior recommendation. The USPSTF targeted its evidence review on the effectiveness and potential harms of screening and the effectiveness and harms of case management to prevent perinatal transmission.The USPSTF previously found adequate evidence that serologic testing for hepatitis B surface antigen accurately identifies HBV infection. Interventions are effective for preventing perinatal

2019 JAMA

124. Effect of Herbal Medicine on Hepatitis C: a Systematic Review and Meta-analysis Full Text available with Trip Pro

Effect of Herbal Medicine on Hepatitis C: a Systematic Review and Meta-analysis '/> '/> '/> '/> Effect of Herbal Medicine on Hepatitis C: a Systematic Review and Meta-analysis E-mail this Article Original Article Eun-jin Kang, Kyong-lim Kim, Kyoung-min Kim DOI : Your Name * Your E-mail * Recipient's E-mail * Message / 500 characters | | | | | > > Article C형간염에 대한 한약의 치료효과 : 체계적 문헌고찰과 메타분석 Original Article The Journal of Internal Korean Medicine 2019; 40(3): 312-330. DOI: C형간염에 대한 한약의 치료효과 : 체계적 (...) 문헌고찰과 메타분석 , , 동의대학교 부속한방병원 한방내과학교실 Effect of Herbal Medicine on Hepatitis C: a Systematic Review and Meta-analysis , , Dept. of Oriental Internal Medicine, College of Oriental Medicine, Dong-Eui University 교신저자: 김경민 부산시 부산진구 양정로 62 동의대학교부속한방병원 TEL: 051-850-8622 FAX: 051-867-5162 E-mail: Received March 29, 2019 Revised July 01, 2019 Accepted July 04, 2019 Copyright: © The Society of Internal Korean Medicine This is an open access article distributed under the terms of the Creative Commons

2019 The Journal of Internal Korean Medicine

125. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update Full Text available with Trip Pro

Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer (...) review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update Ru HAN, Junwen ZHOU, Clément François N, Mondher Toumi Ru HAN Aix-Marseille Universite Corresponding Author ORCiD: https

2019 Research Square

126. Hepatitis B vaccine for renal patients: patient group direction template

Hepatitis B vaccine for renal patients: patient group direction template application/vnd.openxmlformats-officedocument.wordprocessingml.document

2019 Public Health England

127. An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naive chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitut (Abstract)

An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naive chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitut A 12-week grazoprevir/elbasvir regimen is highly effective against hepatitis C virus genotype 1 (HCV-1) infection. The efficacy of an 8-week regimen for treatment-naive HCV-1-infected patients with mild fibrosis has not been

2019 EvidenceUpdates

128. Hepatitis E: symptoms, transmission, prevention, treatment

Hepatitis E: symptoms, transmission, prevention, treatment Hepatitis E: symptoms, transmission, treatment and prevention - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Hepatitis E: symptoms, transmission, treatment and prevention Updated 8 March 2019 Contents © Crown copyright 2019 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view (...) this licence, visit or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: . Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at https://www.gov.uk/government/publications/hepatitis-e-symptoms-transmission-prevention-treatment/hepatitis-e-symptoms-transmission-treatment-and-prevention Background Hepatitis E is an illness of the liver caused

2019 Public Health England

129. IDDF2019-ABS-0212 Real-world effectiveness and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection: a meta-analysis Full Text available with Trip Pro

IDDF2019-ABS-0212 Real-world effectiveness and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection: a meta-analysis IDDF2019-ABS-0212 Real-world effectiveness and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection: a meta-analysis | Gut Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here IDDF2019-ABS-0212 Real-world effectiveness and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection: a meta-analysis Article Text Clinical Hepatology IDDF2019-ABS-0212 Real-world effectiveness and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection: a meta

2019 Clinical Hepatology

130. IDDF2019-ABS-0250 Effectiveness of probiotics in improving minimal hepatic encephalopathy in patients with compensated liver cirrhosis – a meta-analysis Full Text available with Trip Pro

IDDF2019-ABS-0250 Effectiveness of probiotics in improving minimal hepatic encephalopathy in patients with compensated liver cirrhosis – a meta-analysis IDDF2019-ABS-0250 Effectiveness of probiotics in improving minimal hepatic encephalopathy in patients with compensated liver cirrhosis – a meta-analysis | Gut Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here IDDF2019-ABS-0250 Effectiveness of probiotics in improving minimal hepatic encephalopathy in patients with compensated liver cirrhosis – a meta-analysis Article Text Clinical Hepatology IDDF2019-ABS-0250 Effectiveness of probiotics in improving minimal hepatic encephalopathy in patients with compensated liver cirrhosis

2019 Clinical Hepatology

131. IDDF2019-ABS-0295 Polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy: a meta-analysis Full Text available with Trip Pro

IDDF2019-ABS-0295 Polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy: a meta-analysis IDDF2019-ABS-0295 Polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy: a meta-analysis | Gut Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here IDDF2019-ABS-0295 Polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy: a meta-analysis Article Text Clinical Hepatology IDDF2019-ABS-0295 Polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy: a meta-analysis Free Carlos Paolo Dimatatac Francisco , Enrik John Torres Aguila , Ian Homer Yee Cua ), it showed

2019 Clinical Hepatology

132. IDDF2019-ABS-0125 Host genetic factors associated with hepatitis C spontaneous viral clearance: a meta-analysis Full Text available with Trip Pro

IDDF2019-ABS-0125 Host genetic factors associated with hepatitis C spontaneous viral clearance: a meta-analysis IDDF2019-ABS-0125 Host genetic factors associated with hepatitis C spontaneous viral clearance: a meta-analysis | Gut Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? You are here IDDF2019-ABS-0125 Host genetic factors associated with hepatitis C spontaneous viral clearance: a meta-analysis Article Text Basic Hepatology IDDF2019-ABS-0125 Host genetic factors associated with hepatitis C spontaneous viral clearance: a meta-analysis Free Dewi Nur Aisyah , Laura Shallcross , Alice Jane Hully , Alastair O’Brien , Andrew Hayward ) Abstract IDDF2019-ABS-0125 Figure 1 Odd ratio of hcv

2019 Basic Hepatology

133. RISK FACTORS OF HEPATITIS B IN PATIENTS ON HEMODIALYSIS: A SYSTEMATIC REVIEW Full Text available with Trip Pro

RISK FACTORS OF HEPATITIS B IN PATIENTS ON HEMODIALYSIS: A SYSTEMATIC REVIEW ??? 4, ? 2 1 ??????????????? ? ??????????? ???????? ® (...) . Maleva, Olga A. Trubnikova, Olga L. Barbarash STATINS IN PREVENTION OF POSTOPERATIVE COGNITIVE DYSFUNCTION IN PATIENTS AFTER CARDIAC SURGERY (Kemerovo, Russian Federation) Daria V . Kvashnina, Olga V . Kovalishena, Nikolay V . Saperkin RISK FACTORS OF HEPATITIS B IN PATIENTS ON HEMODIALYSIS: A SYSTEMATIC REVIEW (Nizhniy Novgorod, Russian Federation; Utrecht, Netherlands) Natalia V . Tapeshkina, Larisa P. Pochueva, Oksana P. Vlasova ORGANIZING NUTRITION OF SCHOOLCHILDREN: PROBLEMS AND SOLUTIONS

2019 Fundamental and Clinical Medicine

134. IDDF2019-ABS-0045 Comparison of sequential, incremental and concomitant reintroduction regimens of anti-tubercular therapy(ATT) after initial episode of ATT hepatitis: a systematic review and network meta-analysis Full Text available with Trip Pro

IDDF2019-ABS-0045 Comparison of sequential, incremental and concomitant reintroduction regimens of anti-tubercular therapy(ATT) after initial episode of ATT hepatitis: a systematic review and network meta-analysis IDDF2019-ABS-0045 Comparison of sequential, incremental and concomitant reintroduction regimens of anti-tubercular therapy(ATT) after initial episode of ATT hepatitis: a systematic review and network meta-analysis | Gut Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here IDDF2019-ABS-0045 Comparison of sequential, incremental and concomitant reintroduction regimens of anti-tubercular therapy(ATT) after initial episode of ATT hepatitis: a systematic review and network

2019 Clinical Hepatology

135. Hepatic gastrointestinal stromal tumor: Systematic review of an exceptional location Full Text available with Trip Pro

Hepatic gastrointestinal stromal tumor: Systematic review of an exceptional location Hepatic gastrointestinal stromal tumor: Systematic review of an exceptional location BPG is committed to discovery and dissemination of knowledge This Article Full Article (HTML) (56) Full Article (PDF) (15) Academic Content and Language Evaluation of This Article CrossCheck and Google Search of This Article Academic Rules and Norms of This Article Citation of this article Manuel-Vázquez A, Latorre-Fragua R, de (...) la Plaza-Llamas R, Ramia JM. Hepatic gastrointestinal stromal tumor: Systematic review of an exceptional location. World J Meta-Anal 2019; 7(5): 224-233 Corresponding Author of This Article Alba Manuel Vázquez, MD, PhD, Doctor, Surgeon, Surgical Oncologist, General and Digestive Surgery, University Hospital of Guadalajara, Calle donante de sangre s/n, Guadalajara 19002, Spain. alba_manuel_vazquez@hotmail.com Checklist of Responsibilities for the Scientific Editor of This Article Publishing

2019 World journal of meta-analysis

136. From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis Full Text available with Trip Pro

From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis EISSN 2148-5607 Turkish Journal of Gastroenterology Toggle navigation Turkish Journal of Gastroenterology HIGHLY CITED ARTICLES By: Aydin, M. Merve; Akcali, Kamil Can By: Besheer, Tarek; Arafa, Mona M.; Abd El-Maksoud, Mohamed; et al. By: Yilmaz, Ilkay; Dolar, M (...) . Enver; Ozpinar, Haydar By: Demir, Meryem; Deyneli, Oguzhan; Yilmaz, Yusuf By: Tozlu, Mukaddes; Kayar, Yusuf; Ince, Ali Tuzun; et al. By: Bashiri, Mehrnoosh; Akcali, Didem; Coskun, Demet; et al. From cirrhosis to hepatocellul... Poster From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis , , , , , , , 1. Ohio State University College of Medicine, Columbus, Ohio, USA 2. Department of Internal Medicine, Henry Ford Health Systems, Detroit

2019 The Turkish Journal of Gastroenterology

137. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study Full Text available with Trip Pro

Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study Frailty is associated with mortality in patients with cirrhosis. We measured frailty using 3 simple tests and calculated Liver Frailty Index (LFI) scores for patients at multiple ambulatory centers. We investigated associations between LFI scores, ascites, and hepatic encephalopathy (HE) and mortality.Adults without hepatocellular carcinoma who were on the liver transplantation

2019 EvidenceUpdates

138. New Direct-acting Antiviral for Hepatitis C (Epclusa?

New Direct-acting Antiviral for Hepatitis C (Epclusa? MED CHECK April 2019/ Vol.5 No.13 · Page C N o 13 M ED HECK A p r i l 2 0 1 9 Accelerated Approval, Ignoring Harm, is a Crime New Direct-acting Antiviral for Hepatitis C (Epclusa ) Hemorrhage caused by an Anti-influenza Agent, Baloxavir Editorial Accelerated Approval, Ignoring Harm, is a Crime New Products New Direct-acting Antiviral for Hepatitis C (Epclusa ) Advance in hepatitis C with prior treatment failure or decompensated cirrhosis (...) for whom an anti-influenza drug should be effective. However, if you have severe flu symptoms, you may lose appetite and cannot eat. Then, you have to avoid using Xofluza due to the high risk of bleeding. After all, just like Tamiflu, Xofluza has no place in use for influenza infection. Accelerated approval, ignoring harm, is a crime.MED CHECK April 2019/ Vol.5 No.13 · Page New Direct-acting Antiviral for Hepatitis C ( Epclusa ) Advance in hepatitis C with prior treatment failure or decompensated

2019 Med Check - The Informed Prescriber

139. Prevalence of hepatitis C infection among general population and high-risk groups in the EU/EEA: A systematic review update Full Text available with Trip Pro

Prevalence of hepatitis C infection among general population and high-risk groups in the EU/EEA: A systematic review update Prevalence of hepatitis C infection among general population and high-risk groups in the EU/EEA: A systematic review update | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review (...) prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Prevalence of hepatitis C infection among general population and high-risk groups in the EU/EEA: A systematic review update Ru Han, Junwen Zhou, Clément François, MondherToumi Ru Han 1University of Aix-Marseille, Marseille, France; 2Creativ-Ceutical, Luxembourg

2019 Research Square

140. Seroprevalence and geographical distribution of hepatitis C virus in Iranian patients with thalassemia: a systematic review and meta-analysis Full Text available with Trip Pro

Seroprevalence and geographical distribution of hepatitis C virus in Iranian patients with thalassemia: a systematic review and meta-analysis Seroprevalence and geographical distribution of hepatitis C virus in Iranian patients with thalassemia: a systematic review and meta-analysis × Your purchase has been completed. Your documents are now available to view. × Changing the currency will empty your shopping cart. Confirm Cancel Amir Shamshirian , Reza Alizadeh-Navaei , Ali Akbar Pourfathollah (...) , Reza Alipoor and Ali Reza Mohseni Seroprevalence and geographical distribution of hepatitis C virus in Iranian patients with thalassemia: a systematic review and meta-analysis De Gruyter | 2019 DOI: Share Abstract Background Thalassemia as a hereditary hemoglobinopathy is the most common monogenic disease worldwide. Patients with thalassemia require regular blood transfusion, which provides the risk for the transmission of hepatitis C virus (HCV) as the most common post-transfusion infection

2019 Journal of Laboratory Medicine